---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-099185"
form_type: "8-K"
ticker: "BOLD"
cik: "0001782303"
company_name: "Boundless Bio, Inc."
filed_at: "2024-08-20T23:59:59+00:00"
generated_at: "2026-05-31T08:29:55.054723+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Boundless Bio reprices options for execs to $3.56; CEO Hornby holds 1.15M repriced options

## Summary
- Exercise price reduced to $3.56 (Aug 19, 2024 close) for options originally priced at or above $3.71.
- Repriced options may only be exercised at the lower price if held through the Premium End Date (Aug 19, 2026, or earlier change in control or qualifying termination).
- CEO Zachary D. Hornby: 1,147,242 options repriced (original exercise range $4.10–$16.00).
- CMO Klaus Wagner: 316,893 options; CSO Chris Hassig: 292,821 options repriced.
- Repricing intended to retain key employees without incurring dilution from additional equity grants or cash compensation.

## SEC filing metadata
- accession: 0000950170-24-099185
- form_type: 8-K
- ticker: BOLD
- cik: 0001782303
- company_name: Boundless Bio, Inc.
- filed_at: 2024-08-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782303/000095017024099185/0000950170-24-099185-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782303/000095017024099185/bold-20240819.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-099185
- JSON: https://secwatch.observer/filing/0000950170-24-099185.json
- Plain text: https://secwatch.observer/filing/0000950170-24-099185.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.